|
HER2
a proto-oncogenic receptor tyrosine kinase of the EGFR family. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. Not activated by EGF, TGF- alpha and amphiregulin. Amplified in breast cancer. Overexpression induces constitutive activity, and the gene is amplified or overexpressed in up to 30% of breast cancers, correlating with poor survival. The antibody Herceptin is approved for treatment of metastatic breast cancer with HER2 amplification/overexpression. Somatic mutations seen in 4% of lung cancers and also in breast, gastric, ovarian cancer and glioblastoma. One SNP shows predisposition to breast and gastric cancer. Inhibitors: Herceptin, lapatinib, PKI-166, EKB-569, CI-1033. Note: This description may include information from UniProtKB.
|
| Protein type: Protein kinase, TK; Kinase, protein; Protein kinase, tyrosine (receptor); Membrane protein, integral; EC 2.7.10.1; TK group; EGFR family |
|
Cellular Component: microvillus; lateral loop; basolateral plasma membrane; integral to membrane; lipid raft; postsynaptic membrane; membrane; perinuclear region of cytoplasm; apical plasma membrane; cytoplasm; basal plasma membrane; plasma membrane; endosome membrane; nucleus; receptor complex
|
|
Molecular Function: protein C-terminus binding; identical protein binding; nucleotide binding; Hsp90 protein binding; receptor signaling protein tyrosine kinase activity; transmembrane receptor protein tyrosine kinase activity; protein phosphatase binding; protein kinase activity; transferase activity; protein binding; transmembrane receptor activity; protein heterodimerization activity; protein-tyrosine kinase activity; ubiquitin protein ligase binding; transferase activity, transferring phosphorus-containing groups; kinase activity; glycoprotein binding; ATP binding
|
|
Biological Process: myelination; phosphoinositide 3-kinase cascade; positive regulation of cell adhesion; wound healing; positive regulation of translation; protein amino acid autophosphorylation; heart development; motor axon guidance; signal transduction; protein amino acid phosphorylation; positive regulation of transcription from RNA polymerase I promoter; positive regulation of MAP kinase activity; sympathetic nervous system development; cell surface receptor linked signal transduction; glial cell differentiation; positive regulation of MAPKKK cascade; regulation of transcription, DNA-dependent; positive regulation of cell proliferation; response to axon injury; neuromuscular junction development; negative regulation of immature T cell proliferation in the thymus; regulation of microtubule-based process; nervous system development; transcription, DNA-dependent; positive regulation of cell growth; peripheral nervous system development; positive regulation of phosphoinositide 3-kinase cascade; positive regulation of transcription from RNA polymerase III promoter; positive regulation of Ras protein signal transduction; positive regulation of protein amino acid phosphorylation; estrus; phosphorylation; positive regulation of epithelial cell proliferation; transmembrane receptor protein tyrosine kinase signaling pathway; positive regulation of Rho GTPase activity; negative regulation of apoptosis
|
|
Reference #:
P70424 (UniProtKB)
|
| Alt. Names/Synonyms: avian erythroblastosis oncogene B 2; c-erbB-2; c-erbB2; c-neu; Erbb-2; Erbb2; HER-2; HER2; Kiaa3023; mKIAA3023; Neu; Neu oncogene; OTTMUSP00000002540; p185erbB2; Proto-oncogene c-ErbB-2; Proto-oncogene Neu; Receptor tyrosine-protein kinase erbB-2; v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
| Gene Symbols: Erbb2 |
|
Molecular weight: 138,579 Da
|
|
Basal Isoelectric point: 5.65
Predict pI for various phosphorylation states
|
|
CST Pathways:
ErbB/HER Signaling
|
Tyrosine Kinases
|
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology®
|
